Nemaura Medical Inc.
NMRDDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001602078
Nemaura Medical Inc. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Jan 9, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $280.9K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Nemaura Medical Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Nemaura Medical Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Ghadar-Ghadr Arash | Chief Operating Officer | 100,000 | Jan 9, 2024 | 0 |
| Timol Bashir | Chief Business Officer | – | Feb 1, 2022 | 0 |
| Chowdhury Dewan Fazlul Hoque | CEO & President | – | Feb 1, 2022 | 0 |
| Natha Salim | Director | – | Feb 1, 2022 | 0 |
| Mclarney Justin James | Chief Financial Officer | 22,293 | Feb 1, 2022 | 0 |
| Johnson Timothy Christopher | Director | – | Feb 1, 2022 | 0 |
| Moore Thomas Peter | Director | – | Feb 1, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2024 (view filing)5:30 PM ET | Jan 5 | 4 days | Ghadar-Ghadr ArashChief Operating Officer | PPurchase | +100.0K | $0.14 | +$14.0K | New position100.0K after |